Cargando…

VEGF gene transfection restores the angiogenesis of oral submucous fibrosis in mice

BACKGROUND: To explore the effectiveness of adenovirus-enhanced green fluorescent protein-vascular endothelial growth factor165 (AD-EGFP-VEGF165) transfection on fibroblasts from mice, and we assessed whether VEGF165 restores the angiogenesis of oral submucous fibrosis (OSF) in mice. METHODS: AD-EGF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Ying, Wang, Tao, Wen, Qi-Tao, Yu, Da-Hai, Chen, Jing-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263869/ https://www.ncbi.nlm.nih.gov/pubmed/34350245 http://dx.doi.org/10.21037/atm-21-2213

Ejemplares similares

Expression and correlation of the Pi3k/Akt pathway and VEGF in oral submucous fibrosis
por: Lin, Yanan, et al.
Publicado: (2023)

Photobiomodulation therapy inhibits oral submucous fibrosis in mice
por: Chiang, Min‐Hsuan, et al.
Publicado: (2020)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island
por: Li, Bingxia, et al.
Publicado: (2023)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

Buccal fat pad reconstruction for oral submucous fibrosis
por: Surej, Kumar L. K., et al.
Publicado: (2010)

Ultrasonographic Evaluation of Oral Submucous Fibrosis and Masseteric Hypertrophy
por: Devathambi, Jones Raja, et al.
Publicado: (2013)

Prognostic potential of AgNORs in oral submucous fibrosis
por: Murgod, Sanjay, et al.
Publicado: (2016)

Areca nut and its role in oral submucous fibrosis
por: Prabhu, Rachana V., et al.
Publicado: (2014)

Plasma fibrinogen degradation products in oral submucous fibrosis
por: Gupta, Sonia, et al.
Publicado: (2015)

Evaluation of oxidative stress and the microenvironment in oral submucous fibrosis
por: Rai, Vertika, et al.
Publicado: (2019)

Effectiveness of Osteopathic Therapy in the Treatment of Oral Submucous Fibrosis
por: Goyal, Manu, et al.
Publicado: (2017)

Oral submucous fibrosis and COVID-19: Perspective on comorbidity
por: Sarode, Sachin C., et al.
Publicado: (2020)

Research Achievements of Oral Submucous Fibrosis: Progress and Prospect
por: Xu, Hui, et al.
Publicado: (2021)

Determination of Effectiveness of Photobiomodulation in the Treatment of Oral Submucous Fibrosis
por: Sukanya, D., et al.
Publicado: (2022)

The Immunolocalization of Mast Cells in the Pathology of Oral Submucous Fibrosis
por: Gupta, Seema, et al.
Publicado: (2023)

Polyphenol-based targeted therapy for oral submucous fibrosis
por: Mehta, Chetan Hasmukh, et al.
Publicado: (2023)

PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix
por: Wang, Jie, et al.
Publicado: (2017)

Evaluation of Oral Pentoxifylline in the Management of Oral Submucous Fibrosis – An Ultrasonographic Study
por: Sadaksharam, Jayachandran, et al.
Publicado: (2017)

An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis
por: Ahmad, Tanveer, et al.
Publicado: (2021)

Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments
por: Shen, Yen-Wen, et al.
Publicado: (2020)

A prospective transmission electron microscopic study of muscle status in oral submucous fibrosis along with retrospective analysis of 80 cases of oral submucous fibrosis
por: Sumathi, MK, et al.
Publicado: (2012)

Estimation of serum lipids in patients with Oral Submucous Fibrosis in India
por: Ajai, Kratika, et al.
Publicado: (2014)

Serum vitamin c and iron levels in oral submucous fibrosis
por: Guruprasad, R, et al.
Publicado: (2014)

Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis
por: Kamat, Sushant S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_08jv03934ncsltbcdupofoq3k6